Second Half Financial Partners LLC Takes Position in Axon Enterprise, Inc $AXON

Second Half Financial Partners LLC purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 346 shares of the biotechnology company’s stock, valued at approximately $286,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock valued at $4,540,005,000 after acquiring an additional 185,571 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of Axon Enterprise by 15.9% during the 1st quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company’s stock valued at $675,812,000 after acquiring an additional 175,890 shares in the last quarter. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 29.8% during the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after acquiring an additional 212,931 shares in the last quarter. Northern Trust Corp grew its holdings in shares of Axon Enterprise by 1.2% during the 1st quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company’s stock valued at $381,692,000 after acquiring an additional 8,794 shares in the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Axon Enterprise by 23,203.7% during the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock valued at $322,961,000 after acquiring an additional 611,418 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Raymond James Financial restated an “outperform” rating and set a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. JPMorgan Chase & Co. lifted their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective for the company in a research note on Tuesday, August 5th. UBS Group reaffirmed a “neutral” rating and issued a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Bank of America lifted their price objective on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $841.64.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president owned 238,379 shares in the company, valued at $177,892,712.54. This trade represents a 6.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Hadi Partovi bought 1,358 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The stock was purchased at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the acquisition, the director directly owned 237,938 shares in the company, valued at approximately $176,074,120. This trade represents a 0.57% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON opened at $703.03 on Friday. The company has a market capitalization of $55.19 billion, a PE ratio of 173.59, a price-to-earnings-growth ratio of 27.30 and a beta of 1.41. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The company’s fifty day moving average price is $755.57 and its 200 day moving average price is $713.70.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business’s quarterly revenue was up 32.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.